Приказ основних података о документу

dc.creatorVuckovic, S.
dc.creatorProstran, M.
dc.creatorIvanović, Milovan
dc.creatorDošen-Mićović, Ljiljana
dc.creatorTodorović, Zoran B.
dc.creatorNesic, Z.
dc.creatorStojanović, R.
dc.creatorDivac, N.
dc.creatorMikovic, Z.
dc.date.accessioned2018-11-22T00:14:55Z
dc.date.available2018-11-22T00:14:55Z
dc.date.issued2009
dc.identifier.issn0929-8673
dc.identifier.urihttps://cherry.chem.bg.ac.rs/handle/123456789/999
dc.description.abstractFentanyl is the prototype of the 4-anilidopiperidine class of synthetic opioid analgesics. This study was aimed to review the structure-activity-relationship (SAR) of fentanyl analogs substituted in the position 3, or 4 of the piperidine ring. Pharmacological results show that the groups in position 3 of the piperidine ring, which are larger than methyl, severely reduce the analgesic potency compared to fentanyl. It is likely that the steric factor alone (i.e. voluminosity of the group and cis/trans isomerism), rather than the polarity and/or chemical reactivity, plays a crucial role in the analgesic potency of this series. Although the duration of action, in general, does not depend on the stereochemistry, longer action of the most potent 3-alkyl fentanyl analogs such as cis-3-methyl- and cis-3-ethyl fentanyl, is more likely influenced by pharmacodynamic, rather than pharmacokinetic variables. Also, it is possible that the introduction of a functional group such as 3-carbomethoxy reduces the duration of action by altering pharmacokinetic properties. SAR findings obtained by evaluating the neurotoxic effects of fentanyl analogs substituted in the position 3 of the piperidine ring parallel the SAR findings on analgesia in regard to potency and duration of action. This might suggest that similar receptors are involved in producing both antinociceptive and neurotoxic effects of these drugs. It appears that both the potency and the duration of action in the series of fentanyl analogs substituted in position 4 of the piperidine ring is influenced only by the steric requirement and not by the chemical nature of the substituent.en
dc.publisherBentham Science Publ Ltd, Sharjah
dc.relationinfo:eu-repo/grantAgreement/MESTD/MPN2006-2010/145001/RS//
dc.rightsrestrictedAccess
dc.sourceCurrent Medicinal Chemistry
dc.subjectFentanylen
dc.subjectanalogsen
dc.subjectstructure-activity-relationship (SAR)en
dc.subjectanalgesic activityen
dc.subjectneurotoxicityen
dc.titleFentanyl Analogs: Structure-Activity-Relationship Studyen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractИвановић, Милован; Несиц, З.; Стојановиц, Р.; Дивац, Н.; Тодоровиц, З.; Вуцковиц, С.; Миковиц, З.; Простран, М.; Досен-Мицовиц, Љ.;
dc.citation.volume16
dc.citation.issue19
dc.citation.spage2468
dc.citation.epage2474
dc.identifier.wos000268258200008
dc.identifier.doi10.2174/092986709788682074
dc.citation.other16(19): 2468-2474
dc.citation.rankaM21
dc.identifier.pmid19601792
dc.type.versionpublishedVersionen
dc.identifier.scopus2-s2.0-70349386048


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу